NCT01242215View on ClinicalTrials.gov

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

243

Participants

Timeline

Start Date

September 17, 2010

Primary Completion Date

April 25, 2012

Study Completion Date

April 25, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DEVICE

ipragliflozin

oral

DRUG

Placebo

oral

DRUG

Sulfonylurea

oral

Trial Locations (7)

Unknown

Chugoku

Chūbu

Hokkaido

Kansai

Kantou

Kyushu

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY